IFI-M · CUK Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-01986 // MULTI-AXIS · IFI-M

CUK Tri-Axis Dominant-Primary Series III-AG

Mentha × piperita

Peppermint

Tier IIICUK Tri-Axis Dominant-Primary Series

Target Trait

1.95×

fold-change

Cooling-dominant tri-axis U+K modulated fold-change

Technical Specifications

SKU

SS-F-M3-01986

Genomic Edits

10

GC Content

45.6%

Construct Length

5,645 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Receptor Target

TRPM8 + mGluR1 + CaSR

IFI Score

195

Pathway Edits

  • TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent CUK pathway operation
  • Cross-pathway regulatory circuit for cooling-dominant CUK triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPM8, mGluR1, and CaSR pathways simultaneously engineeredCooling-dominant tri-axis expression strategy (CUK) with cross-pathway flux managementT-DNA binary vector 2A11 for stable genomic integration of multi-axis construct stack

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier III CUK triple-axis construct for advanced multi-modal sensory architecture combining cooling, umami, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$1499 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?